← TENET HEALTHCARE CORP

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Total Revenue $19.6b
$19.2b -2.25%
$18.3b -4.52%
$18.5b +0.91%
$18.5b +0.23%
$19.7b +6.23%
$19.4b -1.57%
$20.5b +6.09%
$20.7b +0.57%
$21.3b +3.12%
$22.6b +6.23%
Net losses (gains) on sales, consolidation and deconsolidation of facilities — ($144.0m) ($127.0m) $15.0m ($14.0m) ($445.0m) ($1.0m) ($23.0m) ($2.9b) $1.0m —
Labor and Related Expense $9.4b $9.3b $8.6b $8.7b $8.4b $8.9b $8.8b $9.1b $8.8b $8.7b —
Amortization of Intangible Assets — $172.0m $185.0m $188.0m $172.0m $188.0m $172.0m $174.0m $172.0m $166.0m —
Restructuring Costs — $117.0m $115.0m $137.0m $184.0m $57.0m $118.0m $79.0m $56.0m $44.0m —
Impairment and restructuring charges, and acquisition-related costs $202.0m $541.0m $209.0m $185.0m $290.0m $85.0m $226.0m $137.0m $102.0m $130.0m —
Other operating expenses, net $4.9b $4.6b $4.3b $4.2b $4.1b $4.2b $4.0b $4.5b $4.5b $4.5b —
Operating Income (Loss) $1.2b
$1.1b -8.70%
$1.6b +47.98%
$1.5b -8.14%
$2.0b +31.46%
$2.9b +44.34%
$2.3b -18.74%
$2.5b +7.59%
$6.0b +137.29%
$3.5b -41.10%
$4.4b +25.94%
Gain (Loss) on Investments $8.0m — — — — — — — — — —
Gain (Loss) Related to Litigation Settlement ($293.0m) ($23.0m) ($38.0m) ($141.0m) ($44.0m) ($116.0m) ($70.0m) ($47.0m) ($35.0m) ($64.0m) —
Other Nonoperating Income (Expense) — — ($5.0m) ($5.0m) $1.0m $14.0m $10.0m $19.0m $126.0m $117.0m —
Income (Loss) from Equity Method Investments $131.0m $144.0m $150.0m $175.0m $169.0m $218.0m $216.0m $228.0m $260.0m $264.0m —
Interest Expense (non-operating) $979.0m $1.0b $1.0b $985.0m $1.0b $923.0m $890.0m $901.0m $826.0m $821.0m $820.0m
Income (Loss) from Continuing Operations before Income Taxes, Domestic — — — — — — — — — $2.8b $3.9b
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $248.0m ($101.0m) $639.0m $296.0m $671.0m $1.9b $1.3b $1.6b $5.2b $2.8b $3.9b
Current Income Tax Expense (Benefit) $26.0m $19.0m $27.0m $20.0m $30.0m $161.0m $135.0m $254.0m $1.3b $424.0m $691.0m
Income tax expense ($67.0m) ($219.0m) ($176.0m) ($4.0m) $0 $0 ($344.0m) ($306.0m) ($1.2b) ($433.0m) $691.0m
Income Tax Expense (Benefit) $67.0m $219.0m $176.0m $153.0m ($97.0m) $411.0m $344.0m $306.0m $1.2b $433.0m $691.0m
Net Income (Loss) Available to Common Stockholders, Basic ($192.0m)
($704.0m) -266.67%
$111.0m +115.77%
($232.0m) -309.01%
$399.0m +271.98%
$914.0m +129.07%
$411.0m -55.03%
$611.0m +48.66%
$3.2b +423.73%
$1.4b -56.03%
$2.2b +59.28%
Net Income (Loss) Attributable to Noncontrolling Interest $368.0m $384.0m $355.0m $386.0m $369.0m $562.0m $590.0m $700.0m $864.0m $960.0m $2.2b
Income (Loss) from Continuing Operations, Per Basic Share ($2) ($7) $1 ($2) $4 $9 $4 $6 $33 $16 —
Income (Loss) from Continuing Operations, Per Diluted Share ($2) ($7) $1 ($2) $4 $8 $4 $6 $33 $15 —
Earnings Per Share, Basic ($1.93) ($7.00) $1.09 ($2.24) $3.80 $8.55 $3.84 $6.01 $33.02 $15.61 $26.06
Earnings Per Share, Diluted ($1.93) ($7.00) $1.07 ($2.24) $3.75 $8.42 $3.79 $5.71 $32.70 $15.49 $25.87
Basic (in shares) $99.3m $100.6m $102.1m $103.4m $105.0m $106.8m $106.9m $101.6m $96.9m $90.2m $86.4m
Diluted (in shares) $99.3m $100.6m $103.9m $103.4m $106.3m $108.6m $110.5m $104.8m $97.9m $90.8m $87.0m
Weighted Average Number of Shares Outstanding, Basic 99.3m 100.6m 102.1m 103.4m 105.0m 106.8m 106.9m 101.6m 96.9m 90.2m 86.4m
Weighted Average Number of Shares Outstanding, Diluted 99.3m 100.6m 103.9m 103.4m 106.3m 108.6m 110.5m 104.8m 97.9m 90.8m 87.0m
Additional Financial Items
Business Combination, Acquisition Related Costs $52.0m $22.0m $17.0m $6.0m $14.0m $20.0m $14.0m $15.0m $39.0m $25.0m —
Other Cost and Expense, Operating $4.9b $4.6b $4.3b $4.2b $4.1b $4.2b $4.0b $4.5b $4.5b $4.5b —
Equity in earnings of unconsolidated affiliates $131.0m $144.0m $150.0m $175.0m $169.0m $218.0m $216.0m $228.0m $260.0m $264.0m —
Salaries, wages and benefits $9.4b $9.3b $8.6b $8.7b $8.4b $8.9b $8.8b $9.1b $8.8b $8.7b —
Supplies $3.1b $3.1b $3.0b $3.1b $3.0b $3.3b $3.3b $3.6b $3.6b $3.8b —
Depreciation and amortization $850.0m $870.0m $802.0m $850.0m $857.0m $855.0m $841.0m $870.0m $818.0m $863.0m $893.0m
Litigation and investigation costs $293.0m $23.0m $38.0m $141.0m $44.0m $116.0m $70.0m $47.0m $35.0m $64.0m —
Loss from early extinguishment of debt ($30.0m) ($164.0m) $1.0m ($227.0m) ($316.0m) ($74.0m) ($109.0m) ($11.0m) ($8.0m) ($4.0m) —
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent ($187.0m) ($704.0m) $108.0m ($243.0m) $399.0m $915.0m $410.0m $611.0m $3.2b $1.4b —
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $181.0m ($320.0m) $463.0m $143.0m $768.0m $1.5b $1.0b $1.3b — — —
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest ($5.0m) $0 $3.0m $11.0m $0 ($1.0m) $1.0m $0 — — —
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent ($5.0m) $0 $3.0m $11.0m $0 ($1.0m) $1.0m $0 — — —

Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.